Key result
Moderate-to-severe CAC on CTPA is linked to ~43% higher 30-day adverse events in acute PE.
Why the study?
Does visual assessment of coronary artery calcifications on CT pulmonary angiography predict adverse cardiovascular outcomes and refine risk stratification in patients with acute pulmonary embolism?
Cohort (n=475)
No
Does visual assessment of coronary artery calcifications on CT pulmonary angiography predict adverse cardiovascular outcomes and refine risk stratification in patients with acute pulmonary embolism?
Visual assessment of coronary artery calcifications on routine CTPA independently predicts short- and long-term adverse outcomes in acute pulmonary embolism and reclassifies 22.2% of low- and intermediate-low-risk patients into higher risk categories.
Visual CAC on CTPA was associated with higher 30-day events in acute PE; hypothesis-generating for refining sPESI-based stratification in prospective studies.
Background Coronary artery calcifications (CAC) are frequently detected incidentally on chest CT performed for suspected pulmonary embolism (PE). Their prognostic relevance and potential role in refining PE risk stratification remain insufficiently explored. Purpose To assess the prognostic impact of visually graded CAC on CT pulmonary angiography (CTPA) in patients with acute PE and to evaluate their contribution to reclassifying risk beyond the simplified PESI (sPESI) score and ESC 2019 guidelines. Methods This single center retrospective study included 475 consecutive patients diagnosed with PE by CTPA between 2016 and 2019. CAC were visually graded (0: none, 1: mild, 2: moderate, 3: severe). The primary outcome was a 30-day composite of all-cause death, myocardial infarction (MI), coronary revascularization, stroke, hospitalization for heart failure, and major bleeding. Secondary outcomes included 1- short term outcome: PE related death and all death at 30 days, and 2- Five-year extended MACE including cardiovascular mortality, MI, coronary revascularization, ischemic stroke, peripheral arterial events, and hospitalization for heart failure Results CAC were observed in 70.3% of patients. Moderate-to-severe CAC (grades 2–3) or a history of ischemic heart disease (IHD) were associated with older age and higher comorbidities. Thirty-day all-cause mortality and PE-related death were significantly higher in patients with CAC 2–3 or IHD compared to those without (15.5% vs 6.0%, p=0.0013 and 8.8% vs 2.5%, p=0.0027, respectively). In multivariate Cox analysis adjusted for comorbidities, CAC 2–3 remained an independent predictor of the primary outcome (HR=1.43 [1.07–1.91], p=0.015) and extended MACE (HR=3.22 [1.74–5.97], p<0.001). Integrating CAC grading into the clinical risk model refined the risk stratification, reclassifying 22.2% of low- and intermediate-low–risk patients into higher risk categories. Conclusion Visual CAC assessment on routine CTPA is a simple, and independent predictor of adverse cardiovascular outcomes after PE. At no additional cost or radiation, integrating CAC assessment provides a valuable "safety net" to identify high-risk patients who are underestimated by clinical scores alone.
No takes yet. Share an insight, caveat, or question.
Nguyen et al. (2026) conducted a cohort in Acute pulmonary embolism (n=475). Moderate-to-severe visually graded coronary artery calcifications (CAC grades 2-3) on CTPA vs. No or mild coronary artery calcifications (CAC grades 0-1) or no ischemic heart disease was evaluated on 30-day composite of all-cause death, myocardial infarction, coronary revascularization, stroke, hospitalization for heart failure, and major bleeding (HR 1.43, 95% CI 1.07-1.91, p=0.015). Moderate-to-severe coronary artery calcification on CTPA independently predicted 30-day adverse events after acute pulmonary embolism (HR 1.43; 95% CI 1.07-1.91; p=0.015).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: